A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction

NCT04855201 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Pharmacological effect

Conditions

Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction

Interventions

DRUG: Bocidelpar
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.